Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Escherichia coli 1240

Project description:Escherichia coli 1240 Genome sequencing and assembly

| PRJNA224151 | ENA

Ettlia oleoabundans strain:UTEX 1185

Project description:Ettlia oleoabundans strain:UTEX 1185 Genome sequencing

| PRJNA354501 | ENA

Cryptomonas ovata strain:UTEX LB 2783 | isolate:UTEX LB 2783

Project description:Cryptomonas ovata UTEX 2783 Standard Draft genome sequencing

| PRJNA585755 | ENA